Using CTRenaissance®, Pharmaceutical and Life sciences organizations can now conduct next generation clinical trials in a global clinical development ecosystem and further extend it to the delivery and management of approved patient care.
Integrated Clinical Development Platform Solution based on CTRenaissance® is a configurable, and homogenous computing platform that allows options to leverage existing investments by integrating and exchanging clinical as well as operational data in industry standard; and based on its metadata driven structured content and regulatory information management solutions, CTRenaissance® enables the protocol driven execution of clinical development activities from design, setup, management, analysis, optimization to submission by automating majority of the mundane tasks and manual interventions, thereby allowing business-users to conduct the trial unencumbered.
CTRenaissance® has been designed to meet clinical research as an end-to-end managed workbench for the team and its internal and external partners. The workbench provides secure information driven approach from design to acquiring study data and managing it through its entire life within the portfolio of studies. Based on its real-time, multi-tenant, and services architecture, CTRenaissance® allows pharmaceutical and life sciences industry companies and academia to design, manage, analyze, optimize and submit clinical trials in a seamlessly integrated and scalable manner without geographical and organizational boundaries in private, public or hybrid cloud environment or Software as a Service based individual products.
This integrated approach allows multiple partners and stakeholders to collaborate and innovate under one unified and regulatory compliant platform.